Cardiac resynchronization therapy: strategies for device programming, troubleshooting and follow-up
- PMID: 16177848
- DOI: 10.1007/s10840-005-3247-9
Cardiac resynchronization therapy: strategies for device programming, troubleshooting and follow-up
Abstract
Cardiac resynchronization therapy (CRT) improves symptoms, exercise performance, ventricular function, and survival in patients with left ventricular dysfunction, prolonged QRS, and drug-refractory moderate to severe CHF. The growing application of CRT has created a large number of patients with complicated devices that need follow-up care from general practitioners, cardiologists, heart failure specialists and electro-physiologists. Optimal care of the CRT patient includes recognition and management of peri-implantation complications, optimal programming of atrio-ventricular and sequential ventricular timing, and troubleshooting device-related problems during long-term follow-up. A basic awareness of fundamental device features, the techniques to maximize the response to CRT, and an understanding of stored device data to track the response to therapy provide clinicians the ability to maximize clinical outcomes in the CHF patient. As evolving technology continues to increase the complexity of device therapies, clinicians must understand these therapies in order to properly treat heart failure patients. This work summarizes many of the issues involving early complications of CRT device implant, the strategies to optimize device function, and suggests a scheme for follow-up care of patients with CRT devices.
Similar articles
-
Progress in cardiovascular disease: technical considerations in cardiac resynchronization therapy.Prog Cardiovasc Dis. 2006 Jan-Feb;48(4):239-55. doi: 10.1016/j.pcad.2006.01.001. Prog Cardiovasc Dis. 2006. PMID: 16517246 Review.
-
A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.Circ Arrhythm Electrophysiol. 2013 Jun;6(3):538-45. doi: 10.1161/CIRCEP.113.000135. Epub 2013 Apr 16. Circ Arrhythm Electrophysiol. 2013. PMID: 23592833 Clinical Trial.
-
Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1163-8. doi: 10.1161/CIRCEP.113.000570. Epub 2013 Oct 14. Circ Arrhythm Electrophysiol. 2013. PMID: 24125796 Clinical Trial.
-
Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.Circulation. 2010 Sep 7;122(10):985-92. doi: 10.1161/CIRCULATIONAHA.110.955039. Epub 2010 Aug 23. Circulation. 2010. PMID: 20733097 Clinical Trial.
-
A review of factors contributing to health related quality of life achieved with cardiac resynchronization therapy for heart failure.Minerva Cardioangiol. 2007 Dec;55(6):783-802. Minerva Cardioangiol. 2007. PMID: 18091646 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials